Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Net Margin: 2012-2024

Historic Net Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 20.27%.

  • Amphastar Pharmaceuticals' Net Margin fell 1210.00% to 9.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.81%, marking a year-over-year decrease of 768.00%. This contributed to the annual value of 20.27% for FY2024, which is 87.00% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Net Margin is 20.27%, which was down 4.12% from 21.14% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Net Margin registered a high of 21.14% during FY2023, and its lowest value of 0.31% during FY2020.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Net Margin value was 20.27% (recorded in 2024), while the average stood at 19.67%.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Net Margin crashed by 1,934bps in 2020, and later spiked by 1,419bps in 2021.
  • Amphastar Pharmaceuticals' Net Margin (Yearly) stood at 0.31% in 2020, then spiked by 1,419bps to 14.51% in 2021, then soared by 310bps to 17.61% in 2022, then surged by 354bps to 21.14% in 2023, then slumped by 87bps to 20.27% in 2024.